Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance

Objectives: Guidelines recommend colorectal cancer (CRC) screening by fecal occult blood test (FOBT) or colonoscopy. In 2013, Switzerland introduced reimbursement of CRC screening by mandatory health insurance for 50-69-years-olds, after they met their deductible. We hypothesized that the 2013 reimb...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rémi Schneider, Markus Näpflin, Lamprini Syrogiannouli, Sarah Bissig, Kali Tal, Jean-Luc Bulliard, Cyril Ducros, Oliver Senn, Kevin Selby, Caroline Bähler, Eva Blozik, Reto Auer
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/5902c84a04d44948a4b6ea3d015bf56a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5902c84a04d44948a4b6ea3d015bf56a
record_format dspace
spelling oai:doaj.org-article:5902c84a04d44948a4b6ea3d015bf56a2021-11-09T15:17:05ZChange in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance1661-856410.3389/ijph.2021.1604073https://doaj.org/article/5902c84a04d44948a4b6ea3d015bf56a2021-10-01T00:00:00Zhttps://www.ssph-journal.org/articles/10.3389/ijph.2021.1604073/fullhttps://doaj.org/toc/1661-8564Objectives: Guidelines recommend colorectal cancer (CRC) screening by fecal occult blood test (FOBT) or colonoscopy. In 2013, Switzerland introduced reimbursement of CRC screening by mandatory health insurance for 50-69-years-olds, after they met their deductible. We hypothesized that the 2013 reimbursement policy increased testing rate.Methods: In claims data from a Swiss insurance, we determined yearly CRC testing rate among 50-75-year-olds (2012–2018) and the association with socio-demographic, insurance-, and health-related covariates with multivariate-adjusted logistic regression models. We tested for interaction of age (50–69/70–75) on testing rate over time.Results: Among insurees (2012:355′683; 2018:348′526), yearly CRC testing rate increased from 2012 to 2018 (overall: 8.1–9.9%; colonoscopy: 5.0–7.6%; FOBT: 3.1–2.3%). Odds ratio (OR) were higher for 70–75-year-olds (2012: 1.16, 95%CI 1.13–1.20; 2018: 1.05, 95%CI 1.02–1.08). Deductible interacted with changes in testing rate over time (p < 0.001). The increase in testing rate was proportionally higher among 50-69-years-olds than 70-75-year-olds over the years.Conclusions: CRC testing rate in Switzerland increased from 2012 to 2018, particularly among 50-69-years-olds, the target population of the 2013 law. Future studies should explore the effect of encouraging FOBT or waiving deductible.Rémi SchneiderMarkus NäpflinLamprini SyrogiannouliSarah BissigKali TalJean-Luc BulliardCyril DucrosOliver SennKevin SelbyCaroline BählerEva BlozikReto AuerFrontiers Media S.A.articlecolorectal cancer screeningfecal occult blood testcolonoscopytesting ratesSwiss health insurancePublic aspects of medicineRA1-1270ENInternational Journal of Public Health, Vol 66 (2021)
institution DOAJ
collection DOAJ
language EN
topic colorectal cancer screening
fecal occult blood test
colonoscopy
testing rates
Swiss health insurance
Public aspects of medicine
RA1-1270
spellingShingle colorectal cancer screening
fecal occult blood test
colonoscopy
testing rates
Swiss health insurance
Public aspects of medicine
RA1-1270
Rémi Schneider
Markus Näpflin
Lamprini Syrogiannouli
Sarah Bissig
Kali Tal
Jean-Luc Bulliard
Cyril Ducros
Oliver Senn
Kevin Selby
Caroline Bähler
Eva Blozik
Reto Auer
Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
description Objectives: Guidelines recommend colorectal cancer (CRC) screening by fecal occult blood test (FOBT) or colonoscopy. In 2013, Switzerland introduced reimbursement of CRC screening by mandatory health insurance for 50-69-years-olds, after they met their deductible. We hypothesized that the 2013 reimbursement policy increased testing rate.Methods: In claims data from a Swiss insurance, we determined yearly CRC testing rate among 50-75-year-olds (2012–2018) and the association with socio-demographic, insurance-, and health-related covariates with multivariate-adjusted logistic regression models. We tested for interaction of age (50–69/70–75) on testing rate over time.Results: Among insurees (2012:355′683; 2018:348′526), yearly CRC testing rate increased from 2012 to 2018 (overall: 8.1–9.9%; colonoscopy: 5.0–7.6%; FOBT: 3.1–2.3%). Odds ratio (OR) were higher for 70–75-year-olds (2012: 1.16, 95%CI 1.13–1.20; 2018: 1.05, 95%CI 1.02–1.08). Deductible interacted with changes in testing rate over time (p < 0.001). The increase in testing rate was proportionally higher among 50-69-years-olds than 70-75-year-olds over the years.Conclusions: CRC testing rate in Switzerland increased from 2012 to 2018, particularly among 50-69-years-olds, the target population of the 2013 law. Future studies should explore the effect of encouraging FOBT or waiving deductible.
format article
author Rémi Schneider
Markus Näpflin
Lamprini Syrogiannouli
Sarah Bissig
Kali Tal
Jean-Luc Bulliard
Cyril Ducros
Oliver Senn
Kevin Selby
Caroline Bähler
Eva Blozik
Reto Auer
author_facet Rémi Schneider
Markus Näpflin
Lamprini Syrogiannouli
Sarah Bissig
Kali Tal
Jean-Luc Bulliard
Cyril Ducros
Oliver Senn
Kevin Selby
Caroline Bähler
Eva Blozik
Reto Auer
author_sort Rémi Schneider
title Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
title_short Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
title_full Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
title_fullStr Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
title_full_unstemmed Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
title_sort change in colorectal cancer tests submitted for reimbursement in switzerland 2012–2018: evidence from claims data of a large insurance
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5902c84a04d44948a4b6ea3d015bf56a
work_keys_str_mv AT remischneider changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT markusnapflin changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT lamprinisyrogiannouli changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT sarahbissig changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT kalital changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT jeanlucbulliard changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT cyrilducros changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT oliversenn changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT kevinselby changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT carolinebahler changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT evablozik changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
AT retoauer changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance
_version_ 1718440930752593920